Biopharma Boardroom speaks with Carsten Press, Managing Director at Vetter Pharma, about the company’s expansion of commercial filling capacity, growing demand for pre-sterilised syringes, investments in automation and supply resi... Read more
Biopharma Boardroom speaks with Dr Anthony Bradley, Co-Founder and Chief Scientific Officer at DaltonTx, about how the company is bringing antibody design, structure prediction, developability assessment and experimental evide... Read more
Biopharma Boardroom speaks with Quentin Le Masne de Chermont, Head of Corporate Strategy and Business Development at Grünenthal Group, about the company’s expanded partnership with DKSH, the rollout of four pain medicines acr... Read more
Biopharma Boardroom speaks with Nadia Aelbrecht, Vice President, Head of Infectious Disease at QIAGEN, about rapid diagnostics, antimicrobial resistance and the company’s plans to broaden its infectious disease testing portfolio. ... Read more
HCW Biologics Inc. (the “Company” or “HCW Biologics”), a U.S.-based clinical-stage biopharmaceutical company focused on developing novel fusion immunotherapeutics to treat autoimmune diseases, cancer, and senescence-associat... Read more
Eisai Co., Ltd. and Biogen Inc., announced that once weekly lecanemab-irmb subcutaneous injection (brand name: LEQEMBI IQLIK®) is now available in the U.S. for initiation therapy for early Alzheimer’s disease (AD) in adults with mild cogn... Read more
NanoImaging Services, a cryo-EM CRO, and Proteos, a protein production research partner, have announced the launch of TrueCourse Biosciences, an integrated CRO that brings together advanced capabilities to help pharmaceutical and biotechnolog... Read more
As cell and gene therapies progress towards broader commercialisation, scientific innovation alone is no longer enough. The next generation of therapies must be designed from the outset with potency, manufacturability, scalability, analytical... Read more
© 2026 Biopharma Boardroom. All Rights Reserved.
